100 Clinical Results associated with Amgen Boulder, Inc.
0 Patents (Medical) associated with Amgen Boulder, Inc.
01 Oct 1995·TETRAHEDRON LETTERS
An alternative solid-phase approach to C1-oxytocin
Author: Mayer, John P. ; Heil, James R. ; Munson, Mark C. ; Zhang, Jingwen
A general, solid-phase method based on in situ formation of a cystathionine residue is described.The procedure allows for the introduction of a thioether moiety in place of a native disulfide bond and is illustrated here by the synthesis of C1-oxytocin I.
100 Deals associated with Amgen Boulder, Inc.
100 Translational Medicine associated with Amgen Boulder, Inc.